Detalhe da pesquisa
1.
Interleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Interleukin-6 and Vascular Endothelial Growth Factor A in Colon Cancer Cells and Induce Angiogenesis.
J Biol Chem
; 290(36): 22212-24, 2015 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26209639
2.
Transanal Total Mesorectal Excision Versus Laparoscopic Surgery for Rectal Cancer Receiving Neoadjuvant Chemoradiation: A Matched Case-Control Study.
Ann Surg Oncol
; 23(4): 1169-76, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26597369
3.
The evolving practice of hybrid natural orifice transluminal endoscopic surgery (NOTES) for rectal cancer.
Surg Endosc
; 29(1): 119-26, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24986014
4.
Robotic or transanal total mesorectal excision (TaTME) approach for rectal cancer, how about both? Feasibility and outcomes from a single institution.
J Robot Surg
; 16(1): 149-157, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33704671
5.
Robotic transanal total mesorectal excision assisted by laparoscopic transabdominal approach: A preliminary twenty-case series report.
Asian J Surg
; 43(1): 330-338, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31320234
6.
Transanal total mesorectal excision for rectal cancer: hype or new hope?
J Gastrointest Oncol
; 10(6): 1193-1199, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31949939
7.
Prognostic Values of EPDR1 Hypermethylation and Its Inhibitory Function on Tumor Invasion in Colorectal Cancer.
Cancers (Basel)
; 10(10)2018 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30360391